Skip to content
Thursday 13 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,757.90
-0.69%
DAX
26,292.00
-0.15%
CAC 40
8,649.89
-0.29%
STOXX 50
6,544.28
+0.16%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE

Vaccine

  • Indian Covid mutation declared ‘variant of concern’ over fears of rapid spread

    May 7, 2021

    A coronavirus strain first detected in India has been declared a “variant of concern” over fears that it may be spreading more quickly than the dominant Kent strain. Public Health England (PHE) said it had “moderate confidence” that the Indian mutation, known officially as B16172, spreads at least as quickly as the strain first found in Kent last [...]

  • Covid prevalence drops across England with 1 in 1,180 infected

    May 7, 2021

    The prevalence of Covid-19 infections in England has fallen for the fourth week in a row, although the decline has slowed alongside widespread easing of lockdown restrictions across the country. Data released by the Office for National Statistics (ONS) showed that 1 in 1,180 people in England were estimated to have been infected with coronavirus [...]

  • Germany hits back at US patent waiver proposal for Covid-19 vaccines

    May 7, 2021

    Germany has rejected the Covid-19 vaccine patent proposal today, urging that production capacity is key to boosting vaccine output. The country’s health minister said the primary challenge to increasing production volumes of vaccines is quickly and effectively transferring technology. “The main issue is not patent protection but production capacity,” Jens Spahn, said at a news [...]

  • Under-40s in Britain to be offered alternative to Astrazeneca vaccine

    May 7, 2021

    People under the age of 40 in Britain will be offered an alternative to the Astrazeneca coronavirus vaccine following concerns of rare blood clots. In a press conference this morning, the government’s Joint Committee on Vaccination and Immunisation (JCVI) recommended that adults in the UK aged between 30 and 39 should seek an alternative vaccine. Professor [...]

  • Amid a slow rollout, 24m vaccines sit in freezers in Japan

    May 7, 2021

    Unused Covid-19 vaccines are stacking up in the millions in Japan, as the country prepares to approve two more shots in the coming weeks amid a sluggish inoculation drive. Due to lack of manpower and logistical bottlenecks, Japan’s vaccine rollout has been slow, in a nation culturally sceptical of vaccines and layered with bureaucracy. Japan [...]

  • NHS to deliver vaccines to low-uptake communities in a Ford van

    May 7, 2021

    Ford and the NHS in Essex have joined forces with local health leaders to roll out a vaccine drive using a tailored Transit van to deliver jabs. Despite the UK’s successful vaccine rollout, vaccine uptake is lower among some communities facing access challenges, which the vaccine drive seeks to tackle. “Our goal of giving everyone [...]

  • Tweaked Moderna vaccine ‘effective’ against new Covid variants

    May 6, 2021

    Moderna’s “tweaked” vaccine against new Covid variants that emerged in South Africa and Brazil has successfully neutralised them in laboratory trials, the US company announced last night. Data from a small-scale trial of 40 patients showed that a third dose of either its current coronavirus jab or an experimental new vaccine candidate increases immunity against [...]

  • Over 50s to be offered third Covid ‘booster’ jab to eradicate risk of virus before Christmas

    May 5, 2021

    Over 50s could reportedly be offered a third Covid “booster” vaccination this autumn in a bid to eradicate the threat of the virus before Christmas. Chris Whitty, the chief medical officer for England, is currently supervising two trials, with one involving a jab modified to protect against new variants. The other trial involves a third [...]

  • India hit by vaccine shortage a day before it widened its jabs drive

    April 30, 2021

    India has been hit by a Covid-19 vaccines shortage a day before it had planned to widen its nationwide inoculation programme, authorities said today. It comes as the world’s second-most populous country saw another daily record in new cases, reporting 386,452 infections in the last 24 hours. However, medical experts and journalists have warned that [...]

  • Embattled Covid-19 jab maker Astrazeneca reports $275m of vaccine sales

    April 30, 2021

    Embattled Covid-19 vaccine maker Astrazeneca reported a jump in revenue to $7.32bn in the first quarter, including $275m of coronavirus jab sales. The pharmaceutical giant said revenue grew 15 per cent in the first three months of 2021, and profit after tax jumped from £750m to £1.56bn. It recorded $275m of Covid-19 jab sales after [...]

Posts pagination

  • Previous
  • Page 1
  • …
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • …
  • Page 48
  • Next

Trending Articles

  • Five-star Mayfair hotel hit with HMRC winding-up petition

  • It’s not just Jason Arday, most of sociology is a scam

  • IT consultant ordered to pay £50,000 after being accused of stealing Soho House members’ personal details

  • Revolut takes flight with launch of new airport lounges

  • As it happened: FTSE 100 falls as Iran and US clash over Strait of Hormuz; Oil stockpiles ‘rapidly depleting’

MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook